10x Genomics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-43.54	-182.63	-255.1	-166	-58.22
Depreciation & Amortization	43.82	43.71	43.62	33.01	28.25
Asset Writedown & Restructuring Costs	0.81	3.05	9.85	-	-
Loss (Gain) From Sale of Investments	-	0	1.72	-	-
Stock-Based Compensation	109.12	140.75	166.95	136.85	95.96
Other Operating Activities	0.91	0.52	0.43	1.96	0.08
Change in Accounts Receivable	41.31	26.95	-10.61	-18.95	-34.04
Change in Inventory	27.95	-9.78	7.87	-21.19	-30.13
Change in Accounts Payable	-2.13	-3.35	-6.02	5.86	11.08
Change in Unearned Revenue	0.75	11.21	10.93	3.35	1.54
Change in Other Net Operating Assets	-42.95	-23.78	15.17	-8.49	-35.89
Operating Cash Flow	136.05	6.66	-15.2	-33.61	-21.37
Operating Cash Flow Growth	1941.57%	-	-	-	-
Capital Expenditures	-5.94	-12.39	-48.6	-131.66	-101.28
Cash Acquisitions	-9.27	-	-	-4	-5.45
Sale (Purchase) of Intangibles	-	-1	-0.92	-	-
Investment in Securities	1.77	-19.24	183.02	-215.23	-
Investing Cash Flow	-13.44	-32.63	133.49	-350.89	-106.73
Long-Term Debt Repaid	-	-	-5.81	-5.41	-5.03
Total Debt Repaid	-	-	-5.81	-5.41	-5.03
Net Debt Issued (Repaid)	-	-	-5.81	-5.41	-5.03
Issuance of Common Stock	6.8	10.91	19.48	21.23	40.33
Financing Cash Flow	6.8	10.91	13.67	15.82	35.3
Foreign Exchange Rate Adjustments	0.48	-0.16	-0.03	-0.04	0.23
Net Cash Flow	129.9	-15.22	131.93	-368.72	-92.57
Free Cash Flow	130.12	-5.73	-63.8	-165.27	-122.65
Free Cash Flow Margin	20.24%	-0.94%	-10.31%	-32.00%	-25.01%
Free Cash Flow Per Share	1.04	-0.05	-0.55	-1.45	-1.11
Cash Interest Paid	-	-	0.44	0.84	1.22
Cash Income Tax Paid	2.39	5.64	4.93	3.93	8.66
Levered Free Cash Flow	148.39	59.2	27.63	-92.66	-67.02
Unlevered Free Cash Flow	148.39	59.2	27.65	-92.36	-66.48
Change in Working Capital	24.94	1.25	17.34	-39.42	-87.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.